PROLIFERATIVE AND APOPTOTIC STATUS ON LYMPH NODE SECTIONS, INCLUDING THE PROLIFERATION CENTERS (PC), OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS

被引：0
|
作者：
Sachanas, S. [1 ]
Levidou, G. [2 ]
Angelopoulou, M. [3 ]
Moschogiannis, M. [2 ]
Yiakoumis, X. [2 ]
Vassilakopoulos, T. [3 ]
Kyrtsonis, M. C. [3 ]
Kontopidou, F. [3 ]
Kalpadakis, C. [4 ]
Tsirkinidis, P. [5 ]
Dimitriadou, E. [1 ]
Dimitrakopoulou, A. [6 ]
Kokoris, S. [7 ]
Panayiotidis, P. [3 ]
Papadaki, H. [4 ]
Patsouris, E. [3 ]
Korkolopoulou, P. [3 ]
Pangalis, G. [1 ]
机构：
[1] Athens Med Ctr, Phychikon Branch, Athens, Greece
[2] Athens Med Ctr, Athens, Greece
[3] Univ Athens, Athens, Greece
[4] Univ Crete, Haematol Dept, Iraklion, Greece
[5] 401 Mil Hosp, Athens, Greece
[6] Laikon Gen Hosp, Athens, Greece
[7] Attikon Gen Hosp, Athens, Greece
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0731
引用
收藏
页码：297 / 297
页数：1
相关论文
共 50 条
  • [21] Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays
    M Ciccone
    C Agostinelli
    G M Rigolin
    P P Piccaluga
    F Cavazzini
    S Righi
    M T Sista
    O Sofritti
    L Rizzotto
    E Sabattini
    G Fioritoni
    S Falorio
    C Stelitano
    A Olivieri
    I Attolico
    M Brugiatelli
    P L Zinzani
    E Saccenti
    D Capello
    M Negrini
    A Cuneo
    S Pileri
    Leukemia, 2012, 26 : 499 - 508
  • [22] Ibrutinib Treatment Improves T-Cell Proliferative Ability and Effector Function in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients
    Solman, Isabelle G.
    Taylor, Marlene
    You, Hana
    O'Brien, Susan M.
    Mulligan, Stephen P.
    Byrd, John C.
    Dean, James P.
    James, Danelle F.
    Mongan, Ann
    BLOOD, 2018, 132
  • [23] Cyclin D1 Positive Lymphoid Cells in the Proliferation Centers of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Are Not Due to CCND1 Translocations
    Gradowski, J. F.
    Sargent, R.
    Craig, F. E.
    Swerdlow, S. H.
    LABORATORY INVESTIGATION, 2010, 90 : 298A - 298A
  • [24] Cyclin D1 Positive Lymphoid Cells in the Proliferation Centers of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Are Not Due to CCND1 Translocations
    Gradowski, J. F.
    Sargent, R.
    Craig, F. E.
    Swerdlow, S. H.
    MODERN PATHOLOGY, 2010, 23 : 298A - 298A
  • [25] Development of a Novel Lymph Node-Based 3D Culture System Promoting Chronic Lymphocytic Leukemia Proliferation and Survival
    Haselager, Marco
    Perelaer, Eduard
    Kater, Arnon P.
    Eldering, Eric
    BLOOD, 2020, 136
  • [26] Very Early Effects of Ibrutinib on Tumor and Immune Cells in Blood and Lymph Nodes in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Patients
    Palma, Marzia
    Krstic, Aleksandra
    Berglof, Anna
    Wang, Qing
    Blomberg, Emelie
    Meinke, Stephan
    Kamali-Moghaddam, Masood
    Shen, Qiujin
    Jaremko, Georg
    Lundin, Jeanette
    Kimby, Eva
    Hoglund, Petter
    Mansson, Robert
    Osterborg, Anders
    Smith, Edvard
    BLOOD, 2016, 128 (22)
  • [27] The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia
    Vojdeman, Fie Juhl
    van't Veer, Mars B.
    Tjonnfjord, Geir E.
    Itala-Remes, Maija
    Kimby, Eva
    Polliack, Aaron
    Wu, Ka L.
    Doorduijn, Jeanette K.
    Alemayehu, Wendimagegn G.
    Wittebol, Shulamiet
    Kozak, Tomas
    Walewski, Jan
    Abrahamse-Testroote, Martine C. J.
    van Oers, Marinus H. J.
    Geisler, Christian Hartmann
    LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 594 - 600
  • [28] The Aggressive Molecular Signature of Peripheral Blood Chronic Lymphocytic Leukemia (CLL) Cells From Patients with Bulky Lymphadenopathy Closely Resembles That of CLL Cells From Lymph Nodes
    Mittal, Amit K.
    Iqbal, Javeed
    Gilling, Christine E.
    Moragues, Margaret
    Bociek, R. Gregory
    Aoun, Patricia
    Weisenburger, Dennis D.
    Joshi, Shantaram S.
    BLOOD, 2011, 118 (21) : 1653 - 1653
  • [29] Pro-apoptotic effect of lenalidomide (L) in patients with chronic lymphocytic leukemia (CLL) is possibly mediated through interruption of the phosphaticlylinositol pathway.
    Chanan-Khan, Asher Alban
    Ersing, Noreen
    Krammer, Deborah
    Bernacki, Ralph
    Coignet, Lionel
    Goodrich, David
    Bangia, Naveen
    Padmanabhan, Swami
    Porter, Carl W.
    BLOOD, 2006, 108 (11) : 596A - 596A
  • [30] The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
    Herishanu, Yair
    Perez-Galan, Patricia
    Liu, Delong
    Biancotto, Angelique
    Pittaluga, Stefania
    Vire, Berengere
    Gibellini, Federica
    Njuguna, Ndegwa
    Lee, Elinor
    Stennett, Lawrence
    Raghavachari, Nalini
    Liu, Poching
    McCoy, J. Philip
    Raffeld, Mark
    Stetler-Stevenson, Maryalice
    Yuan, Constance
    Sherry, Richard
    Arthur, Diane C.
    Maric, Irina
    White, Therese
    Marti, Gerald E.
    Munson, Peter
    Wilson, Wyndham H.
    Wiestner, Adrian
    BLOOD, 2011, 117 (02) : 563 - 574
12345